DCM
CMRX

Difesa Capital Management’s Chimerix, Inc. CMRX Stock Holding History

Difesa Capital Management’s Portfolio CMRX Stock Details CMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-42,500
Closed -$273K – 262
2021
Q4 		$273K Buy
+42,500
New +$255K 0.19% 103

Other funds holding CMRX

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Difesa Capital Management's CMRX Position: Q1 2022 in Review

Difesa Capital Management sold out of Chimerix, Inc. (CMRX) in Q1 2022, closing a stake of 42,500 shares — an estimated $273K sold.

Difesa Capital Management first reported a position in CMRX in Q4 2021 and held it in 1 quarter. The position peaked at $273K in Q4 2021. 125 funds tracked by Wall St. Rank hold CMRX as of Q1 2022.

  • Difesa Capital Management reported no remaining Chimerix, Inc. position as of Q1 2022 after selling out during the quarter.
  • Difesa Capital Management sold 42,500 Chimerix, Inc. shares in Q1 2022, an estimated $273K.
  • Difesa Capital Management first reported a position in Chimerix, Inc. in Q4 2021 and held it in 1 quarter.
  • Difesa Capital Management's Chimerix, Inc. position peaked at $273K in Q4 2021.
  • 125 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q1 2022.

Based on Difesa Capital Management's 13F filing for Q1 2022, filed 16 May 2022.